Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation

Archives of Toxicology

Volumn 91, Issue 1, 2017, Pages 231-246

  Efremova, Liudmila ^a   Chovancova, Petra ^a   Adam, Martina ^a   Gutbier, Simon ^a   Schildknecht, Stefan ^a   Leist, Marcel ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Astrocyte; LUHMES; Neuroinflammation; Neuropharmacology; p38 kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 9,12 EPOXY 5,16 BIS[(ETHYLTHIO)METHYL] 2,3,9,10,11,12 HEXAHYDRO 10 HYDROXY 9 METHYL 1 OXO 1H DIINDOLO[1,2,3 FG:3',2',1' KL]PYRROLO[3,4 I][1,6]BENZODIAZOCINE 10 CARBOXYLIC ACID METHYL ESTER; DEXAMETHASONE; INTERLEUKIN 1; MIFEPRISTONE; NITRIC OXIDE; PHOSPHOTRANSFERASE INHIBITOR; RESVERATROL; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; CYTOKINE; HORMONE ANTAGONIST; INTERLEUKIN 1BETA; NEUROPROTECTIVE AGENT; NEUROTOXIN; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; COCULTURE; CONDITIONED MEDIUM; CONTROLLED STUDY; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MONOCULTURE; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL COMMUNICATION; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; SIGNAL TRANSDUCTION; TRANSFORMED CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; CELL COMMUNICATION; CELL LINE, TRANSFORMED; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOKINES; DEXAMETHASONE; HORMONE ANTAGONISTS; HUMANS; INTERLEUKIN-1BETA; MAP KINASE SIGNALING SYSTEM; MICE; MIFEPRISTONE; NEUROGENESIS; NEURONAL PLASTICITY; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PROTEIN KINASE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84962711474     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-016-1702-2     Document Type: Article

References (76)

1. Allen NJ, Barres BA (2009) Glia—more than just brain glue. Nature 457:675–677
2. Avendano BC, Montero TD, Chavez CE, von Bernhardi R, Orellana JA (2015) Prenatal exposure to inflammatory conditions increases Cx43 and Panx1 unopposed channel opening and activation of astrocytes in the offspring effect on neuronal survival. Glia 63(11):2058–2072
3. Bal-Price A, Brown GC (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci Off J Soc Neurosci 21(17):6480–6491
4. Bal-Price A, Moneer Z, Brown GC (2002) Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40(3):312–323
5. Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q et al (2013) Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci USA 110:4069–4074
6. Biber K, Owens T, Boddeke E (2014) What is microglia neurotoxicity (not)? Glia 62:841–854
7. Biesmans S, Acton PD, Cotto C, Langlois X, Ver Donck L, Bouwknecht JA et al (2015) Effect of stress and peripheral immune activation on astrocyte activation in transgenic bioluminescent Gfap-luc mice. Glia 63:1126–1137
8. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69
9. Bodea LG, Wang Y, Linnartz-Gerlach B, Kopatz J, Sinkkonen L, Musgrove R et al (2014) Neurodegeneration by activation of the microglial complement-phagosome pathway. J Neurosci 34:8546–8556
10. Brown GC, Neher JJ (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41:242–247
11. Buffo A, Rolando C, Ceruti S (2010) Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 79:77–89
12. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS et al (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28:264–278
13. Carbone M, Duty S, Rattray M (2012) Riluzole neuroprotection in a Parkinson’s disease model involves suppression of reactive astrocytosis but not GLT-1 regulation. BMC Neurosci 13:38
14. Castillo J, Dávalos A, Alvarez-Sabín J, Pumar JM, Leira R et al (2002) Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 58:624–629
15. Chen Y, Vartiainen NE, Ying W, Chan PH, Koistinaho J, Swanson RA (2001) Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem 77:1601–1610
16. Cipriani S, Desjardins CA, Burdett TC, Xu Y, Xu K, Schwarzschild MA (2012) Protection of dopaminergic cells by urate requires its accumulation in astrocytes. J Neurochem 123:172–181
17. Dodla MC, Mumaw J, Stice SL (2010) Role of astrocytes, soluble factors, cells adhesion molecules and neurotrophins in functional synapse formation: implications for human embryonic stem cell derived neurons. Curr Stem Cell Res Ther 5:251–260
18. Efremova L, Schildknecht S, Adam M, Pape R, Gutbier S, Hanf B et al (2015) Prevention of human dopaminergic neurodegeneration in an astrocytes co-culture system allowing endogenous drug metabolism. Br J Pharmacol 172:4119–4132
19. Falsig J, Latta M, Leist M (2004a) Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J Neurochem 88:181–193
20. Falsig J, Porzgen P, Lotharius J, Leist M (2004b) Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347. J Immunol 173:2762–2770
21. Falsig J, Porzgen P, Lund S, Schrattenholz A, Leist M (2006) The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem 96:893–907
22. Falsig J, van Beek J, Hermann C, Leist M (2008) Molecular basis for detection of invading pathogens in the brain. J Neurosci Res 86:1434–1447
23. Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW (1992) Astrocytes and Parkinson’s disease. Prog Brain Res 94:429–436
24. Gallardo G, Barowski J, Ravits J, Siddique T, Lingrel JB, Robertson J et al (2014) An alpha2-Na/K ATPase/alpha-adducin complex in astrocytes triggers non-cell autonomous neurodegeneration. Nat Neurosci 17:1710–1719
25. Gandelman M, Peluffo H, Beckman JS, Cassina P, Barbeito L (2010) Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. J Neuroinflammation 7:33
26. Gantner F, Leist M, Kusters S, Vogt K, Volk HD, Tiegs G (1996) T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res 229:137–146
27. Gao X, Chen H, Schwarzschild MA, Ascherio A (2011) Use of ibuprofen and risk of Parkinson disease. Neurology 76:863–869
28. Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W (2011) Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2:e167
29. Gegg ME, Clark JB (1036) Heales, SJ (2005) Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity. Brain Res 1–2:1–6
30. Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L et al (2015) Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518:547–551
31. Guizzetti M, Moore NH, Giordano G, Costa LG (2008) Modulation of neuritogenesis by astrocyte muscarinic receptors. J Biol Chem 283:31884–31897
32. Gupta K, Patani R, Baxter P, Serio A, Story D, Tsujita T et al (2012) Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ 19:779–787
33. Hansson O, Castilho RF, Kaminski Schierle GS, Karlsson J, Nicotera P, Leist M et al (2000) Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Exp Neurol 164:102–111
34. Hashioka S, McGeer EG, Miyaoka T, Wake R, Horiguchi J, McGeer PL (2015) Interferon-gamma-induced neurotoxicity of human astrocytes. CNS Neurol Disord: Drug Targets 14(2):251–256
35. Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14(7):463–477
36. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388–405
37. Henn A, Kirner S, Leist M (2011) TLR2 hypersensitivity of astrocytes as functional consequence of previous inflammatory episodes. J Immunol 186:3237–3247
38. Hunter RL, Cheng B, Choi DY, Liu M, Liu S, Cass WA et al (2009) Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. J Neurosci Res 87:1913–1921
39. In’T Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T et al (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 345:1515–1521
40. Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Czlonkowski A, Czlonkowska A (1998) Microglial and astrocytic involvement in a murine model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology 39:167–180
41. Krug AK, Gutbier S, Zhao L, Poltl D, Kullmann C, Ivanova V et al (2014) Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+). Cell Death Dis 5:e1222
42. Kuegler PB, Baumann BA, Zimmer B, Keller S, Marx A, Kadereit S et al (2012) GFAP-independent inflammatory competence and trophic functions of astrocytes generated from murine embryonic stem cells. Glia 60:218–228
43. Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybylkowski A, Czlonkowski A et al (2004) Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson’s disease. Int Immunopharmacol 4:1307–1318
44. Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E, McGeer PL (2010) Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J 24(7):2533–2545
45. Lee M, McGeer E, Kodela R, Kashfi K, McGeer PL (2013a) NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders. Glia 61(10):1724–1734
46. Lee M, McGeer E, McGeer PL (2013b) Neurotoxins released from interferon-gamma-stimulated human astrocytes. Neuroscience 229:164–175
47. Lindholm P, Voutilainen MH, Lauren J, Peranen J, Leppanen VM, Andressoo JO et al (2007) Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448:73–77
48. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK et al (2011) A role for glia in the progression of Rett’s syndrome. Nature 475:497–500
49. Lukovic D, Stojkovic M, Moreno-Manzano V, Jendelova P, Sykova E, Bhattacharya SS et al (2015) Concise review: reactive astrocytes and stem cells in spinal cord injury: good guys or bad guys? Stem Cells 33:1036–1041
50. Ma D, Jin S, Li E, Doi Y, Parajuli B, Noda M et al (2013) The neurotoxic effect of astrocytes activated with toll-like receptor ligands. J Neuroimmunol 254:10–18
51. Mander P, Borutaite V, Moncada S, Brown GC (2005) Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J Neurosci Res 79(1–2):208–215
52. Maragakis NJ, Rothstein JD (2006) Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2:679–689
53. Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Coray T, Mark RJ et al (1997) Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer’s disease. Brain Res Brain Res Rev 23:47–61
54. Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI et al (2014) Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med 20:1147–1156
55. Medeiros R, LaFerla FM (2013) Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony. Exp Neurol 239:133–138
56. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10(5):615–622
57. Orre M, Kamphuis W, Osborn LM, Jansen AH, Kooijman L, Bossers K et al (2014) Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction. Neurobiol Aging 35:2746–2760
58. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M (2007) The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82:95–111
59. Pizzurro DM, Dao K, Costa LG (2014) Astrocytes protect against diazinon- and diazoxon-induced inhibition of neurite outgrowth by regulating neuronal glutathione. Toxicology 318:59–68
60. Puschmann TB, Zanden C, De Pablo Y, Kirchhoff F, Pekna M, Liu J et al (2013) Bioactive 3D cell culture system minimizes cellular stress and maintains the in vivo-like morphological complexity of astroglial cells. Glia 61:432–440
61. Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE et al (2011) Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson’s disease: evidence from observational studies. Cochrane Database Syst Rev. doi:10.1002/14651858.CD008454
62. Robel S, Berninger B, Gotz M (2011) The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci 12:88–104
63. Ruitenberg A, Kalmijn S, de Ridder MA, Redekop WK, van Harskamp F, Hofman A et al (2001) Prognosis of Alzheimer’s disease: the Rotterdam Study. Neuroepidemiology 20:188–195
64. Sandstrom von Tobel J, Zoia D, Althaus J, Antinori P, Mermoud J, Pak HS et al (2014) Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures. Toxicol Lett 230:188–197
65. Schildknecht S, Kirner S, Henn A, Gasparic K, Pape R, Efremova L et al (2012) Characterization of mouse cell line IMA 2.1 as a potential model system to study astrocyte functions. Altex Altern Anim Exp 29:261–274
66. Scholz D, Poltl D, Genewsky A, Weng M, Waldmann T, Schildknecht S et al (2011) Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem 119:957–971
67. Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H et al (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23:3394–3406
68. Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5:146–156
69. Simon BM, Malisan F, Testi R, Nicotera P, Leist M (2002) Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ 9:758–767
70. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7–35
71. Valenza M, Marullo M, Di Paolo E, Cesana E, Zuccato C, Biella G et al (2015) Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington’s disease. Cell Death Differ 22:690–702
72. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6:626–640
73. Walker DG, Kim SU, McGeer PL (1998) Expression of complement C4 and C9 genes by human astrocytes. Brain Res 809(1):31–38
74. Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A et al (2012) Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 287:21384–21395
75. Ward RJ, Colivicchi MA, Allen R, Schol F, Lallemand F, de Witte P, Ballini C et al (2009) Neuro-inflammation induced in the hippocampus of ‘binge drinking’ rats may be mediated by elevated extracellular glutamate content. J Neurochem 111:1119–1128
76. Williams EC, Zhong X, Mohamed A, Li R, Liu Y, Dong Q et al (2014) Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet 23:2968–2980